Athersys (ATHX)
Athersys Capital Expenditures: 0.206M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ATHX Capital Expenditures Rankings
| Overall | 69th percentile | 1373 of 4450 |
| Sector | 54th percentile | 231 of 507 in Healthcare |
| Industry | 40th percentile | 94 of 157 in Biotechnology |
ATHX Capital Expenditures Range, Past 5 Years
| Minimum | 0.00 | Jun 2007 |
| Maximum | 0.327M | Dec 2009 |
| Average | 0.1106M |
About Capex
Capital expenditures are a line item from a company's statement of cash flows (click "Learn More" below for details).
Capex (short for capital expenditures) are incurred when a business spends money to purchase fixed assets or to add value to an existing fixed asset. In accounting, a capital expenditures are added to an asset account, thus increasing the value of the asset.
Examples of capital expenditures include the purchase of a new manufacturing plant, investment in server farms for tech companies, or other purchases of assets expected to help the company earn profits in the future.
Unlike other investments like research and development and marketing spending, capital expenditures are not immediately expensed. Rather, property, plant and equipment acquired using capital expenditures are usually expensed over time through the use of depreciation.
Learn More
You may also be interested in these ATHX related companies
ATHX News
$ARNA $KERX $ATHX cnbc: Greeks repaying $430b due today, to Hedge Funds! wow. that money will be back in US stocks.
about 12 days ago by milroyt
about 12 days ago by milroyt
$ARNA $KERX $ATHX don't forget, Europe's still open and moved up but they're selling what they can get money in. Eur closes: it's better.
about 12 days ago by milroyt
about 12 days ago by milroyt
$KERX $ARNA $ATHX looks like a nice beginning to the day setting up ... good luck to us all!
about 13 days ago by milroyt
about 13 days ago by milroyt
$ATHX earnings out today...? no news anywhere other than that. pls post if you see or know when they announce....
about 13 days ago by milroyt
about 13 days ago by milroyt
EBR: Watchlist/worksheet/4 Trading Ideas: That was $CYTX not $ATHX
about 17 days ago by TheEquitiesRoom
about 17 days ago by TheEquitiesRoom
@selectstock on AMT i saw it 1.44 +.19, showing b/a now 1.50-1.54 on $ATHX. i saw early a.m. mention, dont know the stk. thx for info
about 17 days ago by milroyt
about 17 days ago by milroyt
$ATHX is it a happy sympathy play that $ATHX moved up late on anticipating ++ $ARNA vote?
about 17 days ago by milroyt
about 17 days ago by milroyt
$ATHX moving higher. Does this forshadow positive news for $ARNA? Both companies use same receptor that lorcaserin uses
about 17 days ago by stockeye
about 17 days ago by stockeye
$ATHX forms bearish "Top Triangle" chart pattern. http://stks.co/3JPm
about 46 days ago by RecogniaEvents
about 46 days ago by RecogniaEvents
Athersys (ATHX) Gets U.S. Patent for non-Embryonic Stem Cell Use in Reducing GvHD
Apr 04, 7:03AM Street Insider
Apr 04, 7:03AM Street Insider
$ATHX forms bullish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/36jt
about 61 days ago by RecogniaEvents
about 61 days ago by RecogniaEvents
$ATHX forms bearish "Continuation Diamond" chart pattern. http://stks.co/2lrk
about 79 days ago by RecogniaEvents
about 79 days ago by RecogniaEvents
Athersys to Host Fourth Quarter and Year-End 2011 Financial Results Call
Mar 09, 12:00PM GlobeNewswire
Mar 09, 12:00PM GlobeNewswire
Athersys (ATHX) Reports Positve Data from MultiStem Phase I in HSCT Patients
Feb 01, 3:01PM Street Insider
Feb 01, 3:01PM Street Insider
Athersys Awarded $3.6 Million in Grant Funding for Stem Cell Product Development
Feb 01, 7:09AM Benzinga
Feb 01, 7:09AM Benzinga
Athersys Receives U.S. Patent Covering the Treatment of Cardiovascular Disease With Adult Stem Cells
Jan 04, 7:00AM GlobeNewswire
Jan 04, 7:00AM GlobeNewswire
Athersys to Present at 23rd Annual Piper Jaffray Health Care Conference
Nov 23, 11:00AM GlobeNewswire
Nov 23, 11:00AM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ATHX | 1.40 | -0.02 | -1.41% | 34.58M |
| ATHN | 76.34 | -1.50 | -1.93% | 2.707B |
| ATEC | 1.65 | +0.01 | +0.61% | 147.82M |
| ASUR | 4.98 | +0.02 | +0.40% | 23.06M |
| ASTX | 1.81 | +0.06 | +3.43% | 168.46M |
| ASTMD | 2.05 | -0.01 | -0.49% | |
| ASTM | 2.05 | -0.01 | -0.49% | 79.46M |
| ASTI | 0.5391 | -0.02 | -3.73% | 22.08M |
| ASTE | 28.39 | -0.11 | -0.39% | 644.74M |
| BBOX | 22.22 | +0.19 | +0.86% | 388.41M |
